Maven Securities LTD
Q1 2025 13F-HR Holdings
Net value change ($000)
-856,039
(-20.8%)
New positions
103
Sold out positions
125
Turnover %
62.6%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q4 2024
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| XLP | 15,943 | NEW |
| BA | 7,257 | 887.2% |
| FOXA | 5,237 | NEW |
| NOC | 4,793 | 672.2% |
| SARO | 3,996 | NEW |
| Intra-Cellular Therapies, Inc. | 3,826 | NEW |
| VLO | 3,736 | 1249.5% |
| XOP | 3,684 | NEW |
| NEM | 3,267 | 1118.8% |
| MA | 3,242 | 283.1% |
Top Reduces (Value $000, Stocks/ETFs)
| SPY | -100,283 | -76.6% |
| XLK | -19,153 | -100.0% |
| SMARTSHEET INC | -6,163 | -100.0% |
| FYBR | -6,025 | -86.6% |
| JNP | -5,805 | -100.0% |
| HashiCorp, Inc. | -5,586 | -100.0% |
| EFA | -4,633 | -100.0% |
| XOM | -4,252 | -80.0% |
| AAPL | -4,221 | -100.0% |
| KRE | -4,111 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
2,808,955
(86.0% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|